Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:54 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Eventide Asset Management, LLC | 3,179,837 5.150% | 3,179,837 (New Position) | Filing History |
| 2024-02-14 08:48 am Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 0 0.000% | -3,250,000 (Position Closed) | Filing History |
| 2024-02-12 9:06 pm Unchanged | 2024-02-12 | 13D | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 4,494,851 7.200% | 0 (Unchanged) | Filing History |
| 2024-02-07 07:46 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.970% | 2,437,362 (+78.62%) | Filing History |
| 2024-02-05 09:12 am Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | SPHERA FUNDS MANAGEMENT LTD. | 1,562,907 2.530% | -533,351 (-25.44%) | Filing History |
| 2024-01-16 4:12 pm Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Millennium Management LLC | 911,465 1.500% | -1,381,362 (-60.25%) | Filing History |
| 2023-08-11 4:08 pm Purchase | 2023-08-01 | 13D | Inozyme Pharma, Inc. INZY | Longitude Capital Partners III LLC | 5,841,045 9.900% | 1,666,666 (+39.93%) | Filing History |
| 2023-08-07 9:58 pm Purchase | 2023-08-01 | 13D | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 4,494,851 9.500% | 833,333 (+22.76%) | Filing History |
| 2023-05-31 4:17 pm Purchase | 2023-05-22 | 13G | Inozyme Pharma, Inc. INZY | Millennium Management LLC | 2,292,827 5.200% | 2,292,827 (New Position) | Filing History |
| 2023-05-23 4:48 pm Purchase | 2023-05-12 | 13D | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 3,661,518 8.300% | 447,932 (+13.94%) | Filing History |
| 2023-04-04 08:59 am Purchase | 2023-03-29 | 13D | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 3,213,586 7.400% | 552,432 (+20.76%) | Filing History |
| 2023-03-07 06:01 am Purchase | 2023-03-03 | 13G | Inozyme Pharma, Inc. INZY | SPHERA FUNDS MANAGEMENT LTD. | 2,096,258 5.190% | 2,096,258 (New Position) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Venrock Healthcare Capital Partners II, L.P. | 3,867,749 9.300% | -197,251 (-4.85%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Baker Bros. Advisors LP | 2,168,000 5.100% | 2,168,000 (New Position) | Filing History |
| 2023-02-14 2:54 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 3,086,027 7.640% | 633,390 (+25.82%) | Filing History |
| 2023-02-14 08:38 am Unchanged | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 3,250,000 8.050% | 0 (Unchanged) | Filing History |
| 2023-02-13 12:09 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | CHI Advisors LLC | 2,204,876 5.460% | 2,204,876 (New Position) | Filing History |
| 2023-02-10 10:03 am Sale | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deerfield Mgmt, L.P. | 0 0.000% | -2,344,786 (Position Closed) | Filing History |
| 2023-02-09 11:43 am Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,100,138 7.670% | 1,501,110 (+93.88%) | Filing History |
| 2022-04-29 4:05 pm Purchase | 2022-04-19 | 13G | Inozyme Pharma, Inc. INZY | Venrock Healthcare Capital Partners II, L.P. | 4,065,000 9.800% | 4,065,000 (New Position) | Filing History |